Literature DB >> 16385569

TAK1-mediated stress signaling pathways are essential for TNF-alpha-promoted pulmonary metastasis of murine colon cancer cells.

Min-Kyung Choo1, Hiroaki Sakurai, Keiichi Koizumi, Ikuo Saiki.   

Abstract

We have recently established a TNF-alpha-promoted metastasis model, in which the ability to metastasize to the lung was enhanced by stimulation of cultured colon 26 cells with TNF-alpha before intravenous inoculation. To investigate intracellular events in metastatic cascades of TNF-alpha-treated cancer cells, we have focused on the stress signaling pathways to c-Jun N-terminal kinase (JNK) and p38. Treatment with a specific inhibitor, SP600125 or SB203580, in vitro suppressed TNF-alpha-induced migration and pulmonary metastasis. Activation of endogenous TAK1, a mitogen-activated protein kinase (MAP3K) regulating the JNK and p38 MAPK pathways, was induced rapidly by TNF-alpha, and co-transfection of TAK1 with its activator protein TAB1 stimulated activation of JNK and p38 MAPKs, which led to activation of the transcription factor AP-1. The activation of stress signaling pathways by TAK1 resulted in enhanced migration to fibronectin in vitro and metastasis to the lung in vivo without affecting cell proliferation in vitro and tumor growth in vivo. Moreover, knockdown of endogenous TAK1 using small interfering RNA (siRNA) suppressed the TNF-alpha-induced JNK/p38 activation, migration and pulmonary metastasis. These results indicate that TAK1-mediated stress signaling pathways in cancer cells are essential for TNF-alpha-promoted metastasis to the lung.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16385569     DOI: 10.1002/ijc.21734

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway.

Authors:  Xiaoban Xin; Lijun Zhou; Caleb M Reyes; Feng Liu; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

2.  Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.

Authors:  Juliane Totzke; Deepak Gurbani; Rene Raphemot; Philip F Hughes; Khaldon Bodoor; David A Carlson; David R Loiselle; Asim K Bera; Liesl S Eibschutz; Marisha M Perkins; Amber L Eubanks; Phillip L Campbell; David A Fox; Kenneth D Westover; Timothy A J Haystead; Emily R Derbyshire
Journal:  Cell Chem Biol       Date:  2017-08-17       Impact factor: 8.116

3.  A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer.

Authors:  Hideki Shimaoka; Shinsuke Takeno; Kenji Maki; Takahide Sasaki; Suguru Hasegawa; Yuichi Yamashita
Journal:  Oncol Lett       Date:  2017-06-23       Impact factor: 2.967

Review 4.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

5.  TGFbeta1 expression in colonic mucosa: modulation by dietary lipids.

Authors:  Fiorella Biasi; Cinzia Mascia; Giuseppe Poli
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

6.  A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Authors:  Sabreena Safuan; Sarah J Storr; Poulam M Patel; Stewart G Martin
Journal:  Lymphat Res Biol       Date:  2012-12-05       Impact factor: 2.589

7.  TAK1-mediated serine/threonine phosphorylation of epidermal growth factor receptor via p38/extracellular signal-regulated kinase: NF-{kappa}B-independent survival pathways in tumor necrosis factor alpha signaling.

Authors:  Miki Nishimura; Myoung-Sook Shin; Pattama Singhirunnusorn; Shunsuke Suzuki; Miho Kawanishi; Keiichi Koizumi; Ikuo Saiki; Hiroaki Sakurai
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

Review 8.  TAK1 signaling is a potential therapeutic target for pathological angiogenesis.

Authors:  Linxin Zhu; Suraj Lama; Jiang-Hui Wang; Guei-Sheung Liu; Leilei Tu; Gregory J Dusting
Journal:  Angiogenesis       Date:  2021-05-10       Impact factor: 10.658

9.  Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma.

Authors:  Guo-Dong Zhu; Jing Yu; Zheng-Yu Sun; Yan Chen; Hong-Mei Zheng; Mei-Lan Lin; Shi Ou-Yang; Guo-Long Liu; Jie-Wen Zhang; Feng-Min Shao
Journal:  Cell Death Dis       Date:  2021-07-21       Impact factor: 8.469

10.  Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.

Authors:  Hui-Ling Huang; Chi-Hsiang Chiang; Wen-Chun Hung; Ming-Feng Hou
Journal:  Oncotarget       Date:  2015-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.